Michael Dekner, Takeda - Qepler Summits And Conferences

Michael Dekner

Innovation & External Collaborations
Takeda
Austria
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.

Michael Dekner has studied biotechnology at the University of Life Sciences Vienna. Since graduating 16 years ago he has held positions as scientist in enzyme engineering (Biomin), antibody design (f-Star), since joining Takeda as a supervisor for lyophilization and crimping, manager for process and technology innovation and has lead a team of scientists developing and optimizing fill and finish processes.

Currently Michael holds the position of associate director for innovation and external collaboration

Related Sessions:

Pharmaceutical Lyophilization
Summit 2019

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring and new products development.
  • 13 Feb 2019
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 13 February 2019
BLOCK: MANUFACTURING & PROCESS DEVELOPMENT.
CASE STUDY: Ever tried. Ever failed. No matter. Try again. Fail again. Fail better! A (more) rational approach to lyo cycle development.
  • From trial and error to rational design
  • Experimental setup
  • Mathematical modelling of additional parameters
  • Lessons learned
View Details

2nd Annual Pharmaceutical
Lyophilization Summit 2020

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring, new products development.
  • 12 Feb 2020
  • Berlin, DE
  • Pharma
Day 1: Wednesday, 12 February 2020
CASE STUDY: You don´t need to be great to start, but you need to start to be great – A pilot on multivariate monitoring for a lyophilized Product.
  • Multivariate monitoring for Fill and Finish
  • Challenges and roadblocks
  • Future plans
View Details

3rd Annual Pharmaceutical
Lyophilization Summit 2021

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring, new products development.
  • 29 Jul 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 29 July 2021
CASE STUDY: Aseptic Process Simulation for Lyophilization – Best Practice, an Industry Opinion
  • Aseptic process simulation (APS) for lyophilized products
  • Annex 1 revision in relation to APS
  • Proposed best practice
View Details